News | Radiology Business | June 07, 2018

FDA Releases New Report Assessing Quality, Safety and Effectiveness of Medical Device Servicing

Agency concludes current available evidence is not sufficient to indicate widespread public health concern over device servicing; action steps seek to improve best practices

FDA Releases New Report Assessing Quality, Safety and Effectiveness of Medical Device Servicing

June 7, 2018 — A new report from the U.S. Food and Drug Administration (FDA) discusses the continued quality, safety and effectiveness of servicing of medical devices by original equipment manufacturers (OEMs) and third-party entities.

The report was informed by feedback and comments from an open docket and a public workshop held in 2016, among other information. The public workshop included broad participation by OEMs, independent service organizations, healthcare establishments, biomedical and clinical engineers, healthcare technology management professionals, and professional and trade associations. Based on the available information, the FDA believes the current available evidence is not sufficient to conclude whether or not there is a widespread public health concern related to servicing of medical devices that would justify imposing burdensome regulatory requirements at this time.

The report also concludes:

  • The objective evidence indicates that many OEMs and third-party entities provide high-quality, safe and effective servicing of medical devices;
  • A majority of comments, complaints and adverse event reports alleging that inadequate “servicing” caused or contributed to clinical adverse events and deaths actually pertain to “remanufacturing” and not “servicing”; and
  • The continued availability of third-party entities to service and repair medical devices is critical to the functioning of the U.S. healthcare system.

The report also includes several actions that FDA intends on pursuing, such as:

1. Promote the adoption of quality management principles;

2. Clarify the difference between servicing and remanufacturing;

3. Strengthen cybersecurity practices associated with servicing of medical devices; and

4. Foster evidence development to assess the quality, safety and effectiveness of medical device servicing.

The FDA published the report as a required provision of the 2017 the Food and Drug Administration Reauthorization Act (FDARA).

For more information: www.fda.gov

Related Content

Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software for the medical sector – launched E-shop: the new online store to reach medical professionals more quickly and effectively.
News | Radiology Business | September 27, 2021
September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector –...
Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing
News | Cardiac Imaging | September 23, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by
GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

Getty Images

News | Radiology Business | September 23, 2021
September 23, 2021 — GE has entered into an
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Outlook for 2021 and Beyond. As displayed in the figure below, these six market drivers are projected to result in teleradiology reading service volumes increasing by 21% in 2021 and nearly doubling by 2025. Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Feature | Teleradiology | September 15, 2021 | By Arun Gill
The closely tied relationship between...
Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.

Getty Images

Feature | Information Technology | September 14, 2021 | By Jef Williams
Insignia Medical Systems, a leading UK-based enterprise imaging provider, announced it has been acquired by Intelerad Medical Systems, a global leader in medical image management solutions. The deal signals an important step in expanding next-generation imaging solutions and resources to help modernise hospital trusts across the UK. 

Getty Images

News | Radiology Business | September 08, 2021
September 8, 2021 — Insignia Medical Systems, a leadi
As a result of applying budget neutrality, specialties like interventional radiology and radiation oncology — which have high medical supply and equipment costs and lower clinical labor costs — are slated for potentially significant reimbursement reductions.

Getty Images

News | Radiology Business | August 31, 2021
August 31, 2021 — In the...